Paper429309
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer LJ and 2 others. J Biol Chem, 1979. Cited by 994 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. Papers, record 429309. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/429309
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fructose | Major topic |
| Galactose | Major topic |
| Glucose | Major topic |
| Glutamine | Major topic |
| HeLa Cells | Major topic |
| Adenosine Diphosphate | |
| Adenosine Triphosphate | |
| Citric Acid Cycle | |
| Humans | |
| Kinetics | |
| Lactates | |
| Pentoses |
Source PubMed
Cited by421
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 994 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42801687 | High-Density Type I Collagen Promotes IFN-γ+ CD8+ T Cell Exhaustion via SAT1-ASS1-Mediated Glutamine Accumulation and Ferroptosis in Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42801687 | PubMed |
| 42751120 | Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights. | Genes Dis | 2027 | https://conductscience.org/library/papers/42751120 | PubMed |
| 42564856 | Illuminating spatial dynamics of glutamine metabolism with a sensitive genetically encoded biosensor. | RSC Chem Biol | 2026 | https://conductscience.org/library/papers/42564856 | PubMed |
| 42078537 | Gut microbiota regulates growth retardation in pigs through their metabolites of taurine and butyric acids. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42078537 | PubMed |
| 41976362 | G Protein-Coupled Oestrogen Receptor Actions Targeting the Hallmarks of Cancer in Human Prostate Cells: From Cell Fate to Metabolic Reprogramming. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976362 | PubMed |
| 41766657 | α-Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41766657 | PubMed |
| 41723202 | MicroAge mission: experimental design and hardware for a bespoke culture system supporting tissue-engineered skeletal muscle. | NPJ Microgravity | 2026 | https://conductscience.org/library/papers/41723202 | PubMed |
| 41648179 | Illuminating spatial dynamics of glutamine metabolism with a sensitive genetically encoded biosensor. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648179 | PubMed |
| 41559164 | Metabolic reprogramming enhances oxidative stress resistance in differentiating cardiomyocytes. | Sci Rep | 2026 | https://conductscience.org/library/papers/41559164 | PubMed |
| 41513714 | Streamlined rAAV HeLaS3 producer cell line generation via GS selection. | Sci Rep | 2026 | https://conductscience.org/library/papers/41513714 | PubMed |
| 41488637 | The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signaling. | Front Immunol | 2025 | https://conductscience.org/library/papers/41488637 | PubMed |
| 41369418 | PeriTox-M, a Cell-Based Assay for Peripheral Neurotoxicity with Improved Sensitivity to Mitochondrial Inhibitors. | Cells | 2025 | https://conductscience.org/library/papers/41369418 | PubMed |
| 41142618 | The cancer-induced lactate load and oncologic remodeling hypothesis: lactate as a driver of biosynthesis and epigenetics in cancer. | Front Oncol | 2025 | https://conductscience.org/library/papers/41142618 | PubMed |
| 41127177 | Exploring Sugar-Induced Cell Death (SICD) in Yeast: Implications for Diabetes and Cancer Research. | Front Cell Death | 2025 | https://conductscience.org/library/papers/41127177 | PubMed |
| 40983679 | Slc7a7 licenses macrophage glutaminolysis for restorative functions in atherosclerosis. | Nat Metab | 2025 | https://conductscience.org/library/papers/40983679 | PubMed |
| 40952270 | Fueling Prostate Cancer: The Central Role of Glutamine/Glutamate Metabolic Reprogramming. | Asian Pac J Cancer Prev | 2025 | https://conductscience.org/library/papers/40952270 | PubMed |
| 40944200 | Amino Acids Supplementation in Cancer: What Do We Feed, the Patient or the Tumor? | Nutrients | 2025 | https://conductscience.org/library/papers/40944200 | PubMed |
| 40917745 | Targeting Wnt-driven metabolic adaptations in cancer: integrating glycolysis, glutaminolysis, IDO1-mediated immune evasion, and therapeutic delivery strategies. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40917745 | PubMed |
| 40767658 | Vegetable peptones as a fetal bovine serum substitute in human deciduous tooth pulp stem cell culture. | Einstein (Sao Paulo) | 2025 | https://conductscience.org/library/papers/40767658 | PubMed |
| 40723225 | Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40723225 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/429309
GET https://conductscience.org/api/papers/v1/429309/cited_by?page=2